Pharmaceutical

Oscotec sees highest patent filings and grants during J...

Access and buy GlobalData’s databook on the latest filings and grants activity f...

Dechra Pharmaceuticals sees highest patent filings and ...

Access and buy GlobalData’s databook on the latest filings and grants activity f...

Oramed Pharmaceuticals sees highest patent filings and ...

Access and buy GlobalData’s databook on the latest filings and grants activity f...

Orion sees highest patent filings and grants during May...

Access and buy GlobalData’s databook on the latest filings and grants activity f...

Kiniksa Pharmaceuticals sees highest patent filings and...

Access and buy GlobalData’s databook on the latest filings and grants activity f...

Y-mAbs Therapeutics sees highest patent filings and gra...

Access and buy GlobalData’s databook on the latest filings and grants activity f...

Medicover sees highest patent filings and grants during...

Access and buy GlobalData’s databook on the latest filings and grants activity f...

iTeos Therapeutics sees highest patent filings and gran...

Access and buy GlobalData’s databook on the latest filings and grants activity f...

Rusan Pharma’s API Plant in Ankleshwar Receives USFDA G...

Rusan Pharma's new facility in India will enhance its global capabilities and ex...

Certara sees highest patent filings and grants during J...

Access and buy GlobalData’s databook on the latest filings and grants activity f...

FDA launches new rare disease innovation hub

The new hub will act as a central point of connection and engagement for the rar...

BMS gains EMA validation for Opdivo/Yervoy combo in liv...

The Opdivo/Yervoy combination demonstrated statistically and clinically signific...

Tech leader’s $125m boosts Parker Institutes immunother...

The Parker Institute for Cancer Immunotherapy was founded in 2016 by tech entrep...

Boehringer Ingelheim offers Humira biosimilar at 92% di...

Boehringer Ingelheim will sell an unbranded copycat of Humira through GoodRx for...

Exscientia acquires oral CDK7 inhibitor for $20m, plans...

Exscientia paid $20m in upfront cash and equity to buy its development partner G...

Seventh patient ‘cured’ of HIV among highlights at AIDS...

New global projections and advances in HIV therapies are also on the agenda at t...